Thu, October 26, 2017
Wed, October 25, 2017
Tue, October 24, 2017
Mon, October 23, 2017
Fri, October 20, 2017
Thu, October 19, 2017
Wed, October 18, 2017
Tue, October 17, 2017
Mon, October 16, 2017
Fri, October 13, 2017

Douglas Tsao Maintained (TEVA) at Hold with Decreased Target to $19 on, Oct 20th, 2017


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-19-on-oct-20th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Douglas Tsao of Barclays, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $21 to $19 on, Oct 20th, 2017.

Douglas has made no other calls on TEVA in the last 4 months.



There are 8 other peers that have a rating on TEVA. Out of the 8 peers that are also analyzing TEVA, 4 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Liav Abraham of "Citigroup" Downgraded from Strong Buy to Hold on, Wednesday, August 16th, 2017
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017


These are the ratings of the 4 analyists that currently disagree with Douglas


  • David Risinger of "Morgan Stanley" Maintained at Sell with Decreased Target to $15 on, Thursday, October 5th, 2017
  • Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017
  • Vamil Divan of "JMP Securities" Maintained at Sell with Increased Target to $14 on, Wednesday, September 6th, 2017
  • Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017

Publication Contributing Sources